The structure of the TNFRSF13C promoter enables differential expression of BAFF-R during B cell ontogeny and terminal differentiation

Journal of Immunology

Volumn 185, Issue 2, 2010, Pages 1045-1054

  Mihalcik, Stephen A ^a   Huddleston III, Paul M ^a   Wu, Xiaosheng ^a   Jelinek, Diane F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; DEOXYRIBONUCLEASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR REL; HYBRID PROTEIN; LUCIFERASE; TNFRSF13C PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; B LYMPHOCYTE; BINDING SITE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CHROMATIN IMMUNOPRECIPITATION; COMPUTER MODEL; GEL MOBILITY SHIFT ASSAY; GENE SILENCING; GENETIC CONSERVATION; HUMAN; HUMAN CELL; ONTOGENY; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; BIOLOGY; CELL LINE; CHROMOSOME MAP; CYTOLOGY; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; METABOLISM; METHODOLOGY; MOUSE; RNA INTERFERENCE; SYNTENY; TUMOR CELL LINE;

ANIMALS; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME MAPPING; COMPUTATIONAL BIOLOGY; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION PROFILING; HUMANS; IMMUNOBLOTTING; LUCIFERASES; MICE; POINT MUTATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-REL; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; SYNTENY; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 77955475763     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001120     Document Type: Article

References (24)

1. Moore, P. A., O. Belvedere, A. Orr, K. Pieri, D. W. LaFleur, P. Feng, D. Soppet, M. Charters, R. Gentz, D. Parmelee, et al. 1999. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285: 260-263.
2. Schneider, P., F. MacKay, V. Steiner, K. Hofmann, J. L. Bodmer, N. Holler, C. Ambrose, P. Lawton, S. Bixler, H. Acha-Orbea, et al. 1999. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189: 1747-1756.
3. Yan, M., J. R. Brady, B. Chan, W. P. Lee, B. Hsu, S. Harless, M. Cancro, I. S. Grewal, and V. M. Dixit. 2001. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11: 1547-1552.
4. Schiemann, B., J. L. Gommerman, K. Vora, T. G. Cachero, S. Shulga-Morskaya, M. Dobles, E. Frew, and M. L. Scott. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. [see comment] Science 293: 2111-2114. (Pubitemid 32848063)
5. Stadanlick, J. E., M. Kaileh, F. G. Karnell, J. L. Scholz, J. P. Miller, W. J. Quinn, III, R. J. Brezski, L. S. Treml, K. A. Jordan, J. G. Monroe, et al. 2008. Tonic B cell antigen receptor signals supply an NF-κB substrate for prosurvival BLyS signaling. Nat. Immunol. 9: 1379-1387.
6. Cancro, M. P., and J. F. Kearney. 2004. B cell positive selection: road map to the primary repertoire? J. Immunol. 173: 15-19.
7. Levine, M. H., A. M. Haberman, D. B. Sant'Angelo, L. G. Hannum, M. P. Cancro, C. A. Janeway, Jr., and M. J. Shlomchik. 2000. A B-cell receptor-specific selection step governs immature to mature B cell differentiation. Proc. Natl. Acad. Sci. USA 97: 2743-2748.
8. Wang, H., and S. H. Clarke. 2003. Evidence for a ligand-mediated positive selection signal in differentiation to a mature B cell. J. Immunol. 171: 6381-6388.
9. Castro, I., J. A. Wright, B. Damdinsuren, K. L. Hoek, G. Carlesso, N. P. Shinners, R. M. Gerstein, R. T. Woodland, R. Sen, and W. N. Khan. 2009. B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-κB2. J. Immunol. 182: 7729-7737.
10. Osmond, D. G. 1993. The turnover of B-cell populations. [Published erratum appears in 1993 Immunol. Today 14: 68.] Immunol. Today 14: 34-37.
11. Grumont, R. J., and S. Gerondakis. 1994. The subunit composition of NF-κB complexes changes during B-cell development. Cell Growth Differ. 5: 1321-1331.
12. Grumont, R. J., I. J. Rourke, and S. Gerondakis. 1999. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13: 400-411.
13. Grossmann, M., D. Metcalf, J. Merryfull, A. Beg, D. Baltimore, and S. Gerondakis. 1999. The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects. Proc. Natl. Acad. Sci. USA 96: 11848-11853.
14. Grossmann, M., L. A. O'Reilly, R. Gugasyan, A. Strasser, J. M. Adams, and S. Gerondakis. 2000. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 19: 6351-6360.
15. Tardivel, A., A. Tinel, S. Lens, Q.-G. Steiner, E. Sauberli, A. Wilson, F. Mackay, A. G. Rolink, F. Beermann, J. Tschopp, and P. Schneider. 2004. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF. Eur. J. Immunol. 34: 509-518.
16. Darce, J. R., B. K. Arendt, X. Wu, and D. F. Jelinek. 2007. Regulated expression of BAFF-binding receptors during human B cell differentiation. J. Immunol. 179: 7276-7286.
17. Mackay, F., and S. G. Tangye. 2004. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr. Opin. Pharmacol. 4: 347-354.
18. Mackay, F., F. Sierro, S. T. Grey, and T. P. Gordon. 2005. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr. Dir. Autoimmun. 8: 243-265.
19. Westendorf, J. J., G. J. Ahmann, P. R. Greipp, T. E. Witzig, J. A. Lust, and D. F. Jelinek. 1996. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Leukemia 10: 866-876.
20. Arendt, B. K., M. Ramirez-Alvarado, L. A. Sikkink, J. J. Keats, G. J. Ahmann, A. Dispenzieri, R. Fonseca, R. P. Ketterling, R. A. Knudson, E. M. Mulvihill, et al. 2008. Biologic and genetic characterization of the novel amyloidogenic λ light chain-secreting human cell lines, ALMC-1 and ALMC-2. Blood 112: 1931-1941.
21. Sambrook, J., and D. W. Russell. 2001. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
22. Bell, M. P., P. A. Svingen, M. K. Rahman, Y. Xiong, and W. A. Faubion, Jr. 2007. FOXP3 regulates TLR10 expression in human T regulatory cells. J. Immunol. 179: 1893-1900.
23. Kunsch, C., S. M. Ruben, and C. A. Rosen. 1992. Selection of optimal kB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12: 4412-4421.
24. Jiang, P., W. Yueguo, H. Huiming, Y. Hongxiang, W. Mei, and S. Ju. 2009. B-Lymphocyte stimulator: a new biomarker for multiple myeloma. Eur. J. Haematol. 82: 267-276.